Resmed CDI (ASX:RMD)
Health Care Equipment & Services
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
ASX Bank Shares
LIVE ASX reports: CBA, TLS, IAG, AZJ, RMD, REA, GQG, NWS, AMP & DIS
LIVE ASX reporting season coverage is on The Australian Investors Podcast. Today Owen Rask & Drew Meredith cover Commonwealth Bank of Australia (ASX:CBA), AMP Limited (ASX:AMP), ResMed Inc (ASX:RMD) and more.
August 12, 2022
Editor's picks
CRUNCHED: The ASX 200 is down, but it’s not out
On Wednesday, the Australian share market, or S&P/ASX 200 (INDEXASX: XJO) and All Ordinaries (ASX: XAO), hits its lowest level since 2020. Overnight, however, a firm 0.75% increase in US interest rates allowed the US stock market to bounce 1.5%.
June 16, 2022
Today's ASX news
3 key investor takeaways from the week
Here are my three key investor takeaways from a shortened week that saw the S&P/ASX 200 (ASX: XJO) finish broadly flat.
April 26, 2022
Today's ASX news
ASX 200 morning report – RHC, RIO & AGL shares in focus
The S&P/ASX 200 (ASX:XJO) finished flat on Wednesday as Ramsay Health Care (ASX:RHC) and Rio Tinto (ASX:RIO) shares were in the news.
April 21, 2022
Today's ASX news
ASX 200 morning report – PDL, IRE & ASX lithium shares in focus
It was another weak day for the S&P/ASX 200 (ASX: XJO) on Tuesday as Pendal (ASX:PDL) and Iress (ASX:IRE) shares made headlines.
April 13, 2022
ASX Growth Shares
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
February 25, 2022
ASX Growth Shares
Cochlear share price (ASX:COH) rises 6% on record HY22 report
The Cochlear Limited (ASX: COH) share price has bounced this morning after recording a 28% jump in profit for the first half of FY22.
February 22, 2022
Today's ASX news
ASX 200 morning report – ResMed shares in focus
Australian investors had some respite on Friday, as volatility disappeared and the S&P/ASX 200 (ASX: XJO) gained 2.2% to finish the week.
January 31, 2022
ASX Growth Shares
Resmed (ASX:RMD) boosts profit 12% – is now the time to buy shares?
Homegrown medical device company Resmed Inc (ASX: RMD) has updated the market with its Q2 results, boosting profit 12% year on year.
January 28, 2022